Development of diagnosis and therapy for male infertility ; The infertility-related gene approach including seminal plasma motility inhibitor
男性不育症诊断和治疗的发展;
基本信息
- 批准号:11694320
- 负责人:
- 金额:$ 4.67万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Our aim was to determine the effect of Sg on capacitation, which is the series of transformations that spermatozoa must undergo to become fertile. We induced capacitation by ultrafiltrates of fetal cord blood. It was observed that hyperactivation of the human spermatozoa was suppressed by the existence of Sg. But the dose dependence on the concentration of Sg could not be found because the analysis on the motility pattern of spermatozoa by CASA was very unstable. Using the acrosome reaction as an index, we revealed that Sg suppressed capacitation of the human spermatozoa in the dose dependent manner. By the measurement of chemiluminescence using Xantine oxidase, one mechanism of suppressed capacitation by Sg was interference with O_2 generation during this process. We also found that Sg was degraded by the incubation with the washed spermatozoa and the degradation products also inhibited capacitation of the human spermatozoa. These data suggest that Sg and/or its degradation products may be natural regulators of sperm capacitation.We investigated whether the mutation of the Sg I causes infertility. We have previously reported a deletion of 180 bp in the second exon of the Sg I in 5 infertile men and 8 fertile men, and we also found the smaller products of deleted Sg I(than normal one)in one of these fertile men. The mutation form protein is currently being purified and analyzed to determine the difference in the protein function. Though the SNP analysis of the Sg gene is carried out by the DNA two-dimensional electrophoretic method, presently, it has not been confirmed. It succeeded in the expression of the r-Sg protein with much high activity and high-purity. The antibody that produced this r-Sg as an antigen peculiarly reacted with native Sg and SPMI.
我们的目的是确定Sg对获能的影响,获能是精子必须经历的一系列转化才能生育。我们用胎儿脐带血的超滤液诱导获能。观察到Sg的存在抑制了人精子的过度激活。但由于CASA对精子运动模式的分析很不稳定,未发现Sg浓度与剂量的依赖关系。以顶体反应为指标,我们发现Sg以剂量依赖的方式抑制人精子的获能。用黄嘌呤氧化物酶测定其化学发光表明,Sg抑制获能的机制之一是干扰了这一过程中O2的产生。我们还发现,Sg与洗涤的精子孵育后被降解,降解产物也抑制了人类精子的获能。这些数据表明,Sg和/或其降解产物可能是精子获能的天然调节因素。我们调查了Sg I突变是否导致不育。我们已经报道了5名不育男性和8名生育男性Sg I基因第二外显子180个碱基的缺失,我们还在其中一名生育男性中发现了Sg I缺失的产物(比正常产物更小)。突变形式的蛋白质目前正在进行纯化和分析,以确定蛋白质功能的差异。虽然Sg基因的SNP分析是通过DNA双向电泳法进行的,但目前还没有得到证实。成功地表达了高活性、高纯度的r-Sg蛋白。产生这种r-Sg作为抗原的抗体与天然Sg和SPMI发生特异性反应。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
de Lamirande E,Yoshide K,Yoshiike M,Iwamoto T and Gagnon C: "Semenogelin, the main protein of semen coaglum, inhibits human sperm capacitation by interferring with the superoxide anion generated during this process."Journal of Andrology. (in press). (2001
de Lamirande E、Yoshide K、Yoshiike M、Iwamoto T 和 Gagnon C:“Semenogelin,精液凝块的主要蛋白质,通过干扰在此过程中产生的超氧阴离子来抑制人类精子获能。”《男科学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
de Lamirande E, Yoshida K, Yoshiike M, Iwamoto T and Gagnon C: "Semenogelin, the main protein of semen coaglum, inhibits human sperm capacitation by interferring with the superoxide anion generated during this process."Journal of Andrology. (in press). (2
de Lamirande E、Yoshida K、Yoshiike M、Iwamoto T 和 Gagnon C:“Semenogelin 是精液凝块的主要蛋白质,通过干扰在此过程中产生的超氧阴离子来抑制人类精子获能。”《男科学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Satoh I,Yoshiike M,Yamasaki T,Yoshida K,Takano S and Iwamoto T: "A dot-blot-immunoassay for semen identification using a polyclonal antibody against semenogelin : a powerful seminal maker."Forensic Science International. (in press). (2001)
Satoh I、Yoshiike M、Yamasaki T、Yoshida K、Takano S 和 Iwamoto T:“使用针对精液蛋白的多克隆抗体进行精液鉴定的斑点印迹免疫测定法:一种强大的精液制造者。”法医科学国际。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
de Lamirande E, Yoshida K, Yoshiike M, Iwamoto T and Gagnon C: "Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the wuperoxide anion generated during this process."J.Androl.. (in press).
de Lamirande E、Yoshida K、Yoshiike M、Iwamoto T 和 Gagnon C:“Semenogelin 是精液凝结物的主要蛋白质,通过干扰在此过程中产生的过氧化阴离子来抑制人类精子获能。”J.Androl..(出版中)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y. Kuroki, T. Iwamto, J. Lee, M. Yoshiike, S. Nozawa, T Nishida et al: "Spermatogenic ability is different among males in different Y chromosome lineage"Journal of Human Genetics. 44. 289-292 (1999)
Y. Kuroki、T. Iwamto、J. Lee、M. Yoshiike、S. Nozawa、T Nishida 等人:“不同 Y 染色体谱系的男性生精能力不同”《人类遗传学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWAMOTO Teruaki其他文献
IWAMOTO Teruaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWAMOTO Teruaki', 18)}}的其他基金
Study on new sperm laboratory procedure for appropriate treatment options in the assisted reproductive technology
新的精子实验室程序研究,以在辅助生殖技术中提供适当的治疗选择
- 批准号:
23592383 - 财政年份:2011
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of the laboratory procedure to judge the quality of the sperm which assumed seminal vesicle protein a marker
建立以精囊蛋白为标志物判断精子质量的实验室程序
- 批准号:
20591899 - 财政年份:2008
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification and function analysis of glycoprotein in lamina propria of human testis showing deteriorated spermatogenesis
人睾丸固有层糖蛋白的鉴定和功能分析显示精子发生恶化
- 批准号:
17591706 - 财政年份:2005
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular and cellular biological mechanism of the deteriorated spermatogenesis : analysis of glycoprotein in basal membrane of seminiferous tubules.
精子发生恶化的分子和细胞生物学机制:生精小管基底膜糖蛋白分析。
- 批准号:
15591719 - 财政年份:2003
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of diagnosis and therapy for male infertility ; Clinical genetic research including the analysis of the infertility-related gene
男性不育症诊断和治疗的发展;
- 批准号:
10557145 - 财政年份:1998
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Clinical application of seminal plasma sperm motility inhibitor.
精浆精子活力抑制剂的临床应用。
- 批准号:
06454461 - 财政年份:1994
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A sperm motility inhibitor of seminal plasma.
精浆的精子活力抑制剂。
- 批准号:
05044189 - 财政年份:1993
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for international Scientific Research
A sperm motility inhibitor of human seminal plasma
人精浆精子活力抑制剂
- 批准号:
03454390 - 财政年份:1991
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Clinical application of seminal plasma sperm motility inhibitor.
精浆精子活力抑制剂的临床应用。
- 批准号:
06454461 - 财政年份:1994
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




